spacer
home > ict > summer 2018 > strategic selection
PUBLICATIONS
International Clinical Trials

Strategic Selection

Outsourcing in the clinical research industry continues to grow. Fifteen years ago, the top five global CROs employed 30,000 people. Now, in that group, over 100,000 individuals assist in thousands of clinical trials (1). In an era when new drug candidates are flowing into the clinical pipeline in record numbers, outsourcing is of increasing importance to the research industry. According to The Business Research Company, the global market for clinical trial services to biopharmaceutical and medical device companies is forecast to grow at 12% annually until 2021 Ė an acceleration from its increase of 10% in 2017, when its value became US $44.4 billion (2).

Multiple outsourcing models have developed to satisfy rising demand. Relationships range from full-service CROs to a variety of models with Š la carte sourcing of personnel and teams that specialise in particular functions or services. Sponsors can access highly skilled, individual consultants; augment their staff with a handful of additional lab technicians; or hire small to large functional units to fill gaps in their work capacity.

With so many choices, biopharma and biotechnology sponsors often elect to combine these options in a myriad of ways to best support their studies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jeff Mayhew is Chief Development Officer at LabConnect. As one of the partners who founded the company in 2002, Jeff has three decades of operations and business development experience within the healthcare industry. Before starting LabConnect, he was Founder and Director of Nexus Health Management International, where he was involved in the development of in-patient behavioural health services in Southeast Asia. Prior to that, he served as Vice President of strategic alliance development for Charter Behavioral Health Systems, among other key leadership positions in the healthcare industry.

Elizabeth Koury is Vice President of scientific affairs at LabConnect. She is responsible for leading a team of scientists, sample management professionals, and contract managers strategically supporting clients within the pharma industry. Elizabeth earned a bachelorís degree in biology/allied health from Elizabethtown College, US, and a masterís degree in pharmaceutical chemistry from Lehigh University, US. She has more than 20 years of experience in conducting and overseeing scientific research in the areas of neuroscience, oncology, and immunology.
spacer
Jeff Mayhew
spacer
spacer
spacer
Elizabeth Koury
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials

ERT, the global leader in clinical endpoints data collection, today announced the acquisition of APDM Wearable Technologies (APDM, Inc.), a next-generation provider of wearables and digital biomarkers. The combined company will generate higher-fidelity and more powerful data to enable clinical trials to be more predictable, cost-effective, and efficient. Thereby, reinventing endpoint measurement.
More info >>

White Papers

What is process characterization?

EXPUTEC

Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drugís manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement